Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I Trial of Intraperitoneal LSTA1 in Patients Undergoing Cytoreductive Surgery and HIPEC for Peritoneal Surface Malignancy

NCT06216561 is registered in ClinicalTrials.gov with University of California, San Diego as lead sponsor.

NCT NCT06216561
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06216561 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I Trial of Intraperitoneal LSTA1 in Patients Undergoing Cytoreductive Surgery and HIPEC for Peritoneal Surface Malignancy
Lead sponsor
University of California, San Diego
Phase
Phase 1
Overall status
Withdrawn
Start date
November 30, 2023
Completion date
June 24, 2024
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

appendix cancer, colorectal cancer, ovarian carcinoma, peritoneal metastases